Evidence map›Paper›PMID 30582448›Full record

ArticleCirculation research2019

Tissue Resident CCR2- and CCR2+ Cardiac Macrophages Differentially Orchestrate Monocyte Recruitment and Fate Specification Following Myocardial Injury.

Geetika Bajpai, Andrea Bredemeyer, Wenjun Li, Konstantin Zaitsev, Andrew L Koenig, Inessa Lokshina, Jayaram Mohan, Brooke Ivey, His-Min Hsiao, Carla Weinheimer and 5 more

Registry-linked trialOpen access · bronzeAbstract readComparative StudyVideo-Audio Media
In one paragraph

Article in Circulation research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06299176 (Phase 1 Feasibility and Safety of Whole Heart Radiotherapy for End-stage Heart Failure), which is not on this map. Cited by 469 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
469citing papers in PubMed, 1 pooled it
48.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06299176 phase1enrolling by invitationnot on this mapstarted 2025, after this paper: background citation

Phase 1 Feasibility and Safety of Whole Heart Radiotherapy for End-stage Heart Failure: First In-human Treatments

TypeinterventionalSponsorMcGill University Health Centre/Research Institute of the McGill University Health CentreRan2025 to 2026Enrolled6ConditionsHeart Failure NYHA Class III, Heart Failure NYHA Class IV, End-stage Heart Failure, Heart Failure With Reduced Ejection FractionArmsWhole Heart Radiation Therapy
3 · Its place in the literature

Who cites it

469 citing papers in PubMed, 1 synthesis or guideline pooled it, 685 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Radiation-induced AXL upregulation in CCR2Clinical and translational medicine · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Heart Meets Brain: Insights into Neurocardiac Pathophysiology.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Next-generation molecular imaging of cardiac fibrosis.The international journal of cardiovascular imaging · 2026
    Review
  20. Article

409 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Geetika BajpaiFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Andrea BredemeyerFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Wenjun LiDepartment of Surgery (W.L., H.-M.H., D.K., K.J.L.), Washington University School of Medicine, St. Louis, MO.
Konstantin ZaitsevDepartment of Immunology and Pathology (K.Z., M.A., D.K., K.J.L.), Washington University School of Medicine, St. Louis, MO.
Andrew L KoenigFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Inessa LokshinaFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Jayaram MohanFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Brooke IveyFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
His-Min HsiaoDepartment of Surgery (W.L., H.-M.H., D.K., K.J.L.), Washington University School of Medicine, St. Louis, MO.
Carla WeinheimerFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Attila KovacsFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Slava EpelmanToronto General Hospital Research Institute, Division of Cardiology, University Health Network, ON, Canada (S.E.).
Maxim ArtyomovDepartment of Immunology and Pathology (K.Z., M.A., D.K., K.J.L.), Washington University School of Medicine, St. Louis, MO.
Daniel KreiselDepartment of Surgery (W.L., H.-M.H., D.K., K.J.L.), Washington University School of Medicine, St. Louis, MO.
Kory J LavineFrom the Department of Medicine (G.B., A.B., A.L. Koenig, I.L., J.M., B.I., C.W., A. Kovacs, K.J.L.), Washington University School of Medicine, St. Louis, MO.
Washington University in St. Louis · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
The Role of Neutrophils in Regulating Lung Transplant ToleranceP01AI116501 · NIAID · WASHINGTON UNIVERSITY · PI Wenjun Li · 2015 to 2026
$19.4M
THE ROLE OF ISCHEMIA REPERFUSION INJURY IN LUNG ALLOGRAFT REJECTIONR01HL094601 · NHLBI · WASHINGTON UNIVERSITY · PI Andrew Eric Gelman, Daniel Kreisel · 2009 to 2026
$6.9M
MACROPHAGE HETEROGENEITY IN HEART FAILURE PROGRESSION AND CARDIAC RECOVERYR01HL138466 · NHLBI · WASHINGTON UNIVERSITY · PI LAVINE, KORY J. · 2017 to 2021
$1.9M
Training in Integrative and Systems Biology of Cardiovascular DiseaseT32HL134635 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 2017 to 2021
$1.8M
MACROPHAGE ONTOGENY SHIFTS IN ISCHEMIC HEART DISEASER01HL139714 · NHLBI · WASHINGTON UNIVERSITY · PI LAVINE, KORY J. · 2018 to 2021
$1.5M
EMBRYONIC-DERIVED MACROPHAGES IN CORONARY DEVELOPMENT AND ADULT CORONARY GROWTHK08HL123519 · NHLBI · WASHINGTON UNIVERSITY · PI LAVINE, KORY J. · 2014 to 2018
$715k
Role of ontogeny and niche on human macrophage developmentR21AI148877 · NIAID · WASHINGTON UNIVERSITY · PI LAVINE, KORY J., STURGEON, CHRISTOPHER MICHAEL · 2020 to 2021
$433k
Leukocyte trafficking in thoracic graftsI01BX002730 · VA · ST. LOUIS VA MEDICAL CENTER · PI KREISEL, DANIEL · 2016 to 2025
–
BLRD VA I01 BX002730NHLBI NIH HHS K08 HL123519NHLBI NIH HHS R01 HL094601NHLBI NIH HHS R01 HL138466NHLBI NIH HHS R01 HL139714NHLBI NIH HHS T32 HL134635NIAID NIH HHS P01 AI116501NIAID NIH HHS R21 AI148877NIDDK NIH HHS P30 DK052574
6 · The paper itself

Abstract

rationaleRecent advancements have brought to light the origins, complexity, and functions of tissue-resident macrophages. However, in the context of tissue injury or disease, large numbers of monocytes infiltrate the heart and are thought to contribute to adverse remodeling and heart failure pathogenesis. Little is understood about the diversity of monocytes and monocyte-derived macrophages recruited to the heart after myocardial injury, including the mechanisms that regulate monocyte recruitment and fate specification.

objectiveWe sought to test the hypothesis that distinct subsets of tissue-resident CCR2- (C-C chemokine receptor 2) and CCR2+ macrophages orchestrate monocyte recruitment and fate specification after myocardial injury. METHODS AND

resultsWe reveal that in numerous mouse models of cardiomyocyte cell death (permanent myocardial infarction, reperfused myocardial infarction, and diphtheria toxin cardiomyocyte ablation), there is a shift in macrophage ontogeny whereby tissue-resident macrophages are predominately replaced by infiltrating monocytes and monocyte-derived macrophages. Using syngeneic cardiac transplantation to model ischemia-reperfusion injury and distinguish tissue-resident from recruited cell populations in combination with intravital 2-photon microscopy, we demonstrate that monocyte recruitment is differentially orchestrated by distinct subsets of tissue-resident cardiac macrophages. Tissue-resident CCR2+ macrophages promote monocyte recruitment through an MYD88 (myeloid differentiation primary response 88)-dependent mechanism that results in release of MCPs (monocyte chemoattractant proteins) and monocyte mobilization. In contrast, tissue-resident CCR2- macrophages inhibit monocyte recruitment. Using CD (cluster of differentiation) 169-DTR (diphtheria toxin receptor) and CCR2-DTR mice, we further show that selective depletion of either tissue-resident CCR2- or CCR2+ macrophages before myocardial infarction results in divergent effects on left ventricular function, myocardial remodeling, and monocyte recruitment. Finally, using single-cell RNA sequencing, we show that tissue-resident cardiac macrophages differentially instruct monocyte fate specification.

conclusionsCollectively, these observations establish the mechanistic basis by which monocytes are initially recruited to the injured heart and provide new insights into the heterogeneity of monocyte-derived macrophages.

Indexed as

Cell LineageChemotaxis, LeukocyteAnimalsCell DeathDiphtheria ToxinDisease Models, AnimalHeart TransplantationMacrophage ActivationMacrophagesMice, Inbred C57BLMice, KnockoutMonocytesMyeloid Differentiation Factor 88Myocardial InfarctionMyocardial Reperfusion InjuryMyocytes, CardiacCcr2 protein, mouseDiphtheria ToxinMyd88 protein, mouseMyeloid Differentiation Factor 88Receptors, CCR2inflammationmacrophagesmonocytesmyocardial infarctionreceptors, CCR2

Identifiers

PMID30582448
PMCPMC6626616
OpenAlexW2904624968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.